Marcus Schindler
Chief Tech/Sci/R&D Officer en NOVO NORDISK A/S .
Perfil
Marcus Schindler es Director Científico y Vicepresidente Ejecutivo de Investigación en Novo Nordisk A. Se doctoró en la Universidad de Cambridge.
Cargos activos de Marcus Schindler
Empresas | Cargo | Inicio |
---|---|---|
NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 01/03/2021 |
Antiguos cargos conocidos de Marcus Schindler.
Empresas | Cargo | Fin |
---|---|---|
INNATE PHARMA | Director/Board Member | 28/05/2021 |
The Oxford | Chief Tech/Sci/R&D Officer | 29/02/2008 |
Prosidion Ltd.
Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Chief Tech/Sci/R&D Officer | - |
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Formación de Marcus Schindler.
University of Cambridge | Doctorate Degree |
University of Gottingen | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
INNATE PHARMA | Health Technology |
Empresas privadas | 3 |
---|---|
The Oxford | Consumer Services |
Prosidion Ltd.
Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Health Technology |
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |